-+ 0.00%
-+ 0.00%
-+ 0.00%

OUTLOOK THERAPEUTICS SHARES PLUNGE 61.5% PREMARKET AFTER US FDA DECLINES TO APPROVE EYE DISEASE DRUG

Reuters·01/02/2026 09:04:51

Please log in to view news